Dyfyniad APA

Li, F., Aljahdali, I., & Ling, X. (2019). Cancer therapeutics using survivin BIRC5 as a target: What can we do after over two decades of study? J Exp Clin Cancer Res.

Dyfyniad Arddull Chicago

Li, Fengzhi, Ieman Aljahdali, and Xiang Ling. "Cancer Therapeutics Using Survivin BIRC5 As a Target: What Can We Do After Over Two Decades of Study?" J Exp Clin Cancer Res 2019.

Dyfyniad MLA

Li, Fengzhi, Ieman Aljahdali, and Xiang Ling. "Cancer Therapeutics Using Survivin BIRC5 As a Target: What Can We Do After Over Two Decades of Study?" J Exp Clin Cancer Res 2019.

Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.